The effects of extracorporeal blood purification (oXiris®) in patients with cardiogenic shock who require VA-ECMO (CLEAN ECMO): a prospective, open-label, randomized controlled pilot study.

Crit Care · 2025 · PMC12181899 · PMID 40542431

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In previous pilot randomized controlled trials, hemadsorption with CytoSorb in cardiac arrest survivors showed a trend toward reducing cytokine levels compared with standard care, though the results were not statistically significant [ 29 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.